Healthcare

Dear members interested in the health industry,

In mid-May, China’s State Council hosted a national health system reform conference which set broad priorities. Relevant regulatory bodies subsequently issued annual work plans reflecting key themes, including implementing and expanding the centralized drug procurement pilot program, promoting the reform of public and private hospitals and the health insurance system, and promoting “Internet Plus Healthcare” services. China also released...

USCBC members interested in the health sector,
 
On April 25, the National People’s Congress Standing Committee (NPCSC) released for public consultation several draft laws, including draft revisions to the Drug Administration Law and the second draft of the Vaccine Management Law. Comments are due by May 25, 2019.
 
Revisions highlight the government’s continued focus on ensuring quality, safety, and accessibility of healthcare. The laws both propose more...

USCBC members interested in the health sector,
 
China recently committed to ban fentanyl as a drug class, addressing a US ask in the on-going trade negotiations. Beyond this high-profile move, China has continued to focus on improving the quality, safety, and efficiency of its health sector. Recent developments in this update include measures to allow medical device applicants to communicate with the Center for Device Evaluation prior to submitting applications for examination...

USCBC members interested in the healthcare sector,
 
This healthcare industry update includes an overview of major developments in 2018 that provide some insight on trends and regulations to watch going into 2019. Following the vaccine scandal and institutional overhaul in 2018, there is likely to be greater scrutiny of the health sector in 2019. Other priorities continue to include controlling costs and improving patient access to health services and high-quality treatments,...

USCBC members interested in the healthcare industry:

In November, China’s government and health regulators issued a variety of documents moving forward with implementation of comprehensive health sector reforms. Improving quality and safety remains a core theme of recent regulatory and enforcement developments, particularly as the government has continued to manage the July vaccine safety scandal. Several of the documents also address reforms to the drug and device application and...

Health Insurance and Price Negotiations; Medical Device Approval and Clinical Trial Exemptions; More Clarifications on Government Health Reform

USCBC members interested in the healthcare industry:
 
As part of USCBC’s regular monitoring of government and press sources, we wanted to share the below policy and news updates related to the healthcare sector. As China grapples with demographic challenges and rising cancer rates, the government is making efforts to reduce the...

USCBC members interested in the healthcare industry:
 
As part of USCBC’s regular monitoring of government and press sources, we wanted to share the below policy and news updates related to the healthcare sector. The last month saw an acceleration in health sector reforms, notably with the release of drafts for comment on establishing a drug traceability and Unique Device Identification system. The government also clarified its role in healthcare spending, added drugs to the...

Dear USCBC members interested in the health industry:
  
The China National Drug Administration (CNDA) has released “Draft Guiding Opinions on Establishing a Drug Traceability System” for public comment. The final deadline to submit comments to the CNDA is September 20.
 
The State Administration of Market Regulation (SAMR) also issued a notice seeking comment on “Draft Regulations for Medical Device Unique Identification System”. The final deadline to submit...

USCBC members interested in the healthcare industry:
 
As part of USCBC’s regular monitoring of government and press sources, we wanted to share the below policy and news updates related to the healthcare sector. Topics this edition include enforcement of China’s anti-unfair competition law, government response to the latest vaccine safety scandal and calls to reduce the price of innovative drugs, as well as updates on China’s medical device regulatory reform and private...

Dear USCBC members interested in the healthcare industry:
 
As part of USCBC’s regular monitoring of government and press sources, we recently came across a number of policy and news developments related to healthcare:  

NHFPC to Strengthen Regulation of Unfair Competition
CFDA to Enhance Innovation in the Food and Drug Industries
CFDA Issues New Regulation on Medical Devices Standards
Google, Tencent, and Sequoia Capital Invest in China AI Parma Firm...

Dear USCBC members interested in the healthcare industry:
 
As part of USCBC’s regular monitoring of government and press sources, we recently came across a number of policy and news developments related to healthcare:  

China to Accept Overseas Drug Clinical Trial Data
CFDA to Streamline Administration for Changes to Drug Manufacturing Locations
CFDA Seeks Public Comment on Drug Registration Measures
China to Strengthen Supervision of Infant Formula Milk...

Dear USCBC members interested in the healthcare industry:
 
As part of USCBC’s regular monitoring of government and press sources, we recently came across a number of policy and news developments related to healthcare:  

China to Accept Overseas Drug Clinical Trial Data
CFDA to Streamline Administration for Changes to Drug Manufacturing Locations
CFDA Seeks Public Comment on Drug Registration Measures
China to Strengthen Supervision of Infant Formula Milk...

Dear USCBC members interested in the healthcare industry:

As part of USCBC’s regular monitoring of government and press sources, we recently came across a number of policy and news developments related to healthcare:  

CFDA Policies Could Improve Efficiency for Foreign Drug and Device Companies
CFDA Notice on Supervision of Medical Device Testing Institutions
NHFPC Opinion on Establishing Tier 3 Public Hospital Accountant System
CFDA Opinion on Regulating...

Dear USCBC members interested in the healthcare industry:

As part of USCBC’s regular monitoring of government and press sources, we recently came across a number of policy and news developments related to healthcare:  

Private Doctor and Registered Nurse Numbers Continue to Grow

MOST Issues the Thirteenth Five-Year Plan on Biotechnology Innovation

State Council Issues Notice on Deepening Medical and Healthcare...

Dear USCBC members interested in the healthcare industry:

As part of USCBC’s regular monitoring of government and press sources, we recently came across a number of policy and news developments related to healthcare:  

MOHRSS Notice on Negotiated Drug Catalog for Various Insurance Types

CFDA on Clinical Drug Trial Data and Product Inspection

CFDA on Substandard Pharmaceutical Materials Batches

CFDA...

Dear USCBC members interested in the healthcare industry:

 

As part of USCBC’s regular monitoring of government and press sources, we recently came across a number of policy and news developments related to healthcare:

...

Dear USCBC members interested in the healthcare industry:

 

As part of USCBC’s regular monitoring of government and press sources, we recently came across a number of policy and news developments related to healthcare:

...

Dear USCBC members interested in the healthcare industry:

As part of USCBC’s regular monitoring of government and press sources, we recently came across a number of policy and news developments related to healthcare:

NPC Standing Committee Examines Drug Administration Law State Council Issues Plan on Pension and Elderly Care System Key Medicare Points in the 2017 Government Report State Council Publishes 13th Five-Year Plan on Promoting Basic Public Service...